#senescent cells

2 stories

#ai #ai-designed #anti-aging #biotech #clinical trial #dermatology #immorta bio #immune cells #preclinical studies #rubedo life sciences #senolytic peptide #skin aging

Immorta Bio finishes AI senolytic peptide trials
Immorta Bio completes preclinical studies for AI-designed senolytic peptide.
RuntimeWire · 1m
Rubedo's cream shows skin can age backwards
A topical drug targeting senescent cells reduced skin's biological age by two years in early trials, though experts urge caution about what aging clocks actually measure.
WIRED · 1m